Clinical Trial

Posterior Mesh Fixation at the Levator Ani Level in Apical Pelvic Organ Prolapse

Study acronym: FIMEA
Completed
View on ClinicalTrials.gov →
Summary
This is a prospective, randomized, multicenter, non-inferiority trial including women with stage II-IV apical pelvic organ prolapse (POP), classified according to the POP-Q system. Participants will be randomized into two groups: Group A: laparoscopic colposacropexy with posterior mesh fixation to the levator ani muscle. Group B: laparoscopic colposacropexy with posterior mesh fixation to the vaginal cuff/cervix, without dissection of the rectovaginal space. The objective of the study is to determine whether a simplified colposacropexy technique is non-inferior to the standard procedure in terms of anatomical and functional outcomes. The primary outcome is anatomical success, defined as a postoperative POP-Q stage 0-I. Secondary outcomes include functional status and sexual function, evaluated using the PFDI-20 and PISQ-12 questionnaires. Data on prolapse anatomy, related symptoms, and sexual function will be collected at baseline and during follow-up visits at 1, 6, and 12 months after surgery. This study is supported by a national health research grant from the Instituto de Salud Carlos III (ISCIII), Ministry of Science and Innovation, Spain.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-18.
Status change: Active, Not Recruiting → Completed 2026-02-08
Trial Details
NCT Number NCT07194343
Lead Sponsor Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Collaborators: Carlos III Health Institute, Ministry of Science and Innovation, Spain
Conditions Prolapse Genital, Prolapse Uterovaginal, Prolapse; Female
Enrollment 190 participants
Start Date 2022-10-06
Primary Completion 2025-10-31 (estimated)
Study Completion 2025-10-31 (estimated)
Updated on ClinicalTrials.gov 2026-02-10